Definitions in hemophilia: communication from the SSC of the ISTH

被引：590

作者：

Blanchette, V. S. ^{[1
]}

Key, N. S. ^{[2
,3
]}

Ljung, L. R. ^{[4
,5
]}

Manco-Johnson, M. J. ^{[6
]}

Van Den Berg, H. M. ^{[7
]}

Srivastava, A. ^{[8
]}

机构：

[1] Univ Toronto, Hosp Sick Children, Dept Pediat, Pediat Thrombosis & Hemostasis Program, Toronto, ON M5S 1A1, Canada

[2] UNC Hemophilia & Thrombosis Ctr Chapel Hill, Dept Med, Hill, NC USA

[3] UNC Hemophilia & Thrombosis Ctr Chapel Hill, Dept Pathol, Hill, NC USA

[4] Lund Univ, Dept Paediat, Skanes Univ Sjukhus, Malmo, Sweden

[5] Lund Univ, Malmo Ctr Thrombosis & Haemostasis, Skanes Univ Sjukhus, Malmo, Sweden

[6] Univ Colorado, Sch Med, Hemophilia & Thrombosis Ctr, Aurora, CO USA

[7] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[8] Christian Med Coll & Hosp, Dept Hematol, Vellore, Tamil Nadu, India

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2014年 / 12卷 / 11期

关键词：

SEVERE FACTOR-VIII; NIJMEGEN MODIFICATION; BETHESDA ASSAY; C INHIBITORS; PROPHYLAXIS; IX; OUTCOMES; BOYS;

D O I：

10.1111/jth.12672

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1935 / 1939

页数：5

共 19 条

[1] A LONGITUDINAL-STUDY OF ORTHOPEDIC OUTCOMES FOR SEVERE FACTOR-VIII-DEFICIENT HEMOPHILIACS [J].

ALEDORT, LM ;

HASCHMEYER, RH ;

PETTERSSON, H ;

EIBL, H ;

GILBERT, M ;

HILGARTNER, M ;

KUNSHACK, M ;

LARRIEU, MJ ;

LEVINE, P .

JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) :391-399

[2] Consensus perspectives on prophylactic therapy for haemophilia:: summary statement [J].

Berntorp, E ;

Astermark, J ;

Björkman, S ;

Blanchette, VS ;

Fischer, K ;

Giangrande, PLF ;

Gringeri, A ;

Ljung, RC ;

Manco-Johnson, MJ ;

Morfini, M ;

Kilcoyne, RF ;

Petrini, P ;

Rodriguez-Merchan, EC ;

Schramm, W ;

Shapiro, A ;

Van Den Berg, HM ;

Hart, C .

HAEMOPHILIA, 2003, 9 :1-4

[3]

BJORKMAN S, 1992, CLIN PHARMACOKINET, V22, P385

[4] A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres [J].

Blanchette, VS ;

McCready, M ;

Achonu, C ;

Abdolell, M ;

Rivard, G ;

Manco-Johnson, MJ .

HAEMOPHILIA, 2003, 9 :19-26

[5] Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition) [J].

Collins, Peter W. ;

Chalmers, Elizabeth ;

Hart, Daniel P. ;

Liesner, Ri ;

Rangarajan, Savita ;

Talks, Kate ;

Williams, Mike ;

Hay, Charles R. .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (02) :153-170

[6] Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction [J].

Dardikh, M. ;

Albert, T. ;

Masereeuw, R. ;

Oldenburg, J. ;

Novakova, I. ;

van Heerde, W. L. ;

Verbruggen, B. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) :706-708

[7] Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management) [J].

Donadel-Claeyssens, S .

HAEMOPHILIA, 2006, 12 (02) :124-127

[8] The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia [J].

Fischer, K ;

van der Bom, JG ;

Mauser-Bunschoten, EP ;

Roosendaal, G ;

Prejs, R ;

de Kleijn, P ;

Grobbee, DE ;

van den Berg, M .

BLOOD, 2002, 99 (07) :2337-2341

[9]

Giles AR, 1998, THROMB HAEMOSTASIS, V79, P872

[10] A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) [J].

Gringeri, A. ;

Lundin, B. ;

von Mackensen, S. ;

Mantovani, L. ;

Mannucci, P. M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) :700-710

← 1 2 →